SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-100750
Filing Date
2019-04-08
Accepted
2019-04-08 16:30:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d732172dsc13da.htm SC 13D/A 226025
  Complete submission text file 0001193125-19-100750.txt   227413
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Subject) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-77935 | Film No.: 19737709
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12575 ULINE DRIVE PLEASANT PRAIRIE WI 53158
Business Address
Uihlein Richard E (Filed by) CIK: 0001694903 (see all company filings)

Type: SC 13D/A